<DOC>
	<DOCNO>NCT01041326</DOCNO>
	<brief_summary>This Phase I dose-escalation study moderate dose radiation therapy prior radical prostatectomy patient high-risk localized disease . Its hypothesis treatment well tolerate similar side effect profile surgery alone . Patients Groups 1 2 receive 39.6 Gy 45 Gy ( 1.8 Gy/fx ) , respectively , whole pelvis . Patients Groups 3 4 receive 45 Gy whole pelvis , follow boost prostate periprostatic tissue , total dose 50.4 54 Gy , respectively . The patient undergo radical prostatectomy 4-8 week completion radiation .</brief_summary>
	<brief_title>Preoperative Radiation Therapy High Risk Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Subjects must biopsyconfirmed `` highrisk '' prostate cancer , define A. PSA &gt; 20 , B. Gleason Score ( GS ) &gt; /= 8 , and/or C. Clinical stage T3 disease per AJCC Staging Manual , 6th edition ; D. At least two three follow : PSA 1019.9 , GS = 7 , clinical stage = T2b / T2c . negative bone scan , medically fit undergo surgery determine treat urologist , age &gt; 18 , KPS must &gt; /= 80 , prior pelvic radiation therapy , chemotherapy , androgen deprivation , prior invasive malignancy , except non melanomatous skin cancer unless disease free minimum 5 year . Carcinoma insitu bladder head neck region permissible . Subjects must freely sign informed consent enroll study . prior pelvic radiation therapy , chemotherapy , androgen deprivation , prior invasive malignancy , except non melanomatous skin cancer , carcinoma insitu bladder head neck region , unless disease free minimum 5 year . Metastatic disease demonstrate bone scan , CT scan MRI pelvis , chest xray . Pathologically documented positive pelvic lymph node . If Preoperative CT scan MRI ( order discretion treat physician ) demonstrate lymph node suspicious involvement , biopsy must undertake node proven negative patient enroll trial . Declared highrisk anesthesia attend anesthesiologist , cardiologist , physician . History prior pelvic radiation therapy . History androgen deprivation therapy chemotherapy .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>prostatectomy</keyword>
	<keyword>radiation</keyword>
	<keyword>neoadjuvant</keyword>
</DOC>